Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Change in Intangibles (2024 - 2025)

Historic Change in Intangibles for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q1 2025 value amounting to $3.5 million.

  • Day One Biopharmaceuticals' Change in Intangibles changed N/A to $3.5 million in Q1 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 7953.22%. This contributed to the annual value of $17.1 million for FY2024, which is N/A changed from last year.
  • As of Q1 2025, Day One Biopharmaceuticals' Change in Intangibles stood at $3.5 million.
  • Day One Biopharmaceuticals' 5-year Change in Intangibles high stood at $17.1 million for Q2 2024, and its period low was $3.5 million during Q1 2025.